Preparation of genetically homogeneous antigen-specific thymidine kinase positive T-lymphocyte clones for the control of alloreactivity post-bone marrow transplantation

Human Gene Therapy

Volumn 15, Issue 6, 2004, Pages 542-552

  Clémenceau, Béatrice ^a   Gallot, Géraldine ^a   Lemoine, François M ^b   Klatzmann, David ^b   Vié, Henri ^a,c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE; HLA DP ANTIGEN; LEUKOCYTE ANTIGEN; THY 1 ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL POPULATION; CONTROLLED STUDY; GENETIC TRANSDUCTION; GENOMICS; HUMAN; HUMAN CELL; IMMUNIZATION; MOLECULAR CLONING; PARTICLE SIZE; T LYMPHOCYTE; TRANSGENE; CELL CLONE; CELL CULTURE; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; GIBBON LEUKEMIA VIRUS; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; RETROVIRUS; SUICIDE TRANSGENE; TRANSPLANTATION;

GIBBON APE LEUKEMIA VIRUS;

ANTIGENS, CD; ANTIGENS, THY-1; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CLONE CELLS; GENES, TRANSGENIC, SUICIDE; HLA-DP ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOMAGNETIC SEPARATION; IMMUNOTHERAPY; LEUKEMIA VIRUS, GIBBON APE; LYMPHOCYTE ACTIVATION; RETROVIRIDAE; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

EID: 16544365259     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404323141999     Document Type: Article

References (25)

1. BONINI, C., FERRARI, G., VERZELETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
2. BOURGAULT, I., GOMEZ, A., GOMARD, E., and LEVY, J.P. (1991). Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin. Exp. Immunol. 84, 501-507.
3. BURAKOFF, S.J., DEEG, H.J., and FERRARA, J., and ATKINSON K., eds. (1990). Graft-Versus-Host Disease: Immunology, Pathophysiology and Treatment. Hematology, Vol. 12. (Marcel Dekker, New York).
4. BURROWS, S.R., KHANNA, R., BURROWS, J.M., and MOSS, D.J. (1994). An alloresponse in humans is dominated by cytotoxic T lym-phocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: Implication for graft-versus-host disease. J. Exp. Med. 179, 1155-1161.
5. BURROWS, S.R., SILINS, S.L., KHANNA, R., BURROWS, J.M., RISCHMUELLER, M., MCCLUSKEY, J., and MOSS, D.J. (1997). Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 27, 1726-1736.
6. CONTASSOT, E., FERRAND, C., CERTOUX, J.M., REYNOLD, C.W., JACOB, W., CHIANG, Y., CAHN, J.Y., HERVE, P., and TIBERGHIEN, P. (1998). Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytes. Hum. Gene Ther. 9, 73-80.
7. GALLOT, G., HALLET, M.M., GASCHET, J., MOREAU, J.F., VIVIEN, R., BONNEVILLE, M., MILPIED, N., and VIE H. (1996). Human HLA-specific T-cell clones with stable expression of a suicide gene: A possible tool to drive and control a graft-versus-host-graft-versus-leukemia reaction? Blood 88, 1098-1103.
8. GALLOT, G., VIVIEN, R., IBISCH, C., LULE, J., DAVRINCHE, C., GASCHET, J., and VIE, H. (2001). Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4(+) or CD8(+) cytomegalovirus phosphoprotein pp65 epitope determination. J. Immunol. 167, 4196-4206.
9. GARIN, M.I., GARRETT, E., TIBERGHIEN, P., APPERLEY, J.F., CHALMERS, D., MELO, J.V., and FERRAND, C. (2001). Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 97, 122-129.
10. GASCHET, J., MAHE, B., MILPIED, N., DEVILDER, M.C., DRENO, B., BIGNON, J.D., DAVODEAU, F., HALLET M.M., BONNEVILLE, M., and VIE, H. (1993). Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow-transplantation. J. Clin. Invest. 91, 12-20.
11. GASCHET, J., TREVINO, M.A., CHEREL, M., VIVIEN, R., GARCIA-SAHUQUILLO, A., HALLET M.M., BONNEVILLE, M., HARROUSSEAU, J.L., BRAGADO, R., MILPIED, N., and VIE, H. (1996a). HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood 87, 2345-2353.
12. GASCHET, J., LIM, A., LIEM, L., VIVIEN, R., HALLET, M.M., HAROUSSEAU, J.L., EVEN, J., GOULMY, E., BONNEVILLE, M., MILPIED, N., and VIE, H. (1996b). Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. J. Clin. Invest. 98, 100-107.
13. GASCHET, J., GALLOT, G., IBISCH, C., LIM, A., EVEN, J., VIVIEN, R., HALLET, M.M., MILPIED, N., and VIE, H. (1998). Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: Involvement of different TCRBV subsets. Bone Marrow Transplant. 22, 385-392.
14. HESLOP, H.E., BOLLARD, C.M., GOTTSCHALK, S., KUEHNLE, I., HULS, M.H., GEE, A.P., BRENNER, M.K., and ROONEY, C.M. (2002). Immune therapy for EBV infections after hemopoietic stem-cell transplant. Cytotherapy 4, 433-434.
15. HOROWITZ, M.M., GALE, R.P., SONDEL, P.M., GOLDMAN, J.M., KERSEY, J., KOLB, H.J., RIMM, A.A., RINGDEN, O., ROZMAN, C., SPECK, B., et al. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562.
16. IBISCH, C., GALLOT, G., VIVIEN, R., DIEZ, E., JOTTEREAU, F., GARAND, R., and VIE, H. (1999). Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: A perspective for adjuvant immunotherapy post-bone marrow transplantation. Bone Marrow Transplant. 23, 1153-1159.
17. IBISCH, C., SAULQUIN, X., GALLOT, G., VIVIEN, R., FERRAND, C., TIBERGHIEN, P., HOUSSAINT, E., and VIE, H. (2000). The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection. J. Immunol. 164, 4924-4932.
18. KAMINSKI, E., HOWS, J., MAN, S., BROOKES, P., MACKINNON, S., HUGHES, T., AVAKIAN, O., GOLDMAN, J.M., and BATCHELOR, J.R. (1989). Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48, 608-613.
19. KOEHNE, G., GALLARDO, H.F., SADELAIN, M., and O'REILLY, R.J. (2000). Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood 96, 109-117.
20. LEMOINE, F.M., MESEL-LEMOINE M., CHERAI, M., GALLOT, G., VIÉ, H., LECLERCQ, V., TRÉBEDEN-NÈGRE, H., MAMMÈS, O., BOYER, O., NOGUIEZ-HELLIN, P., and KLATZMANN, D. (2004). Efficient transduction and selection of human T-lymphocytes with bicistronic Thy-1/HSV1-TK retroviral vector produced by a human packaging cell line. J. Gene Med. 6, 374-386.
21. LUCAS, K.G., SMALL, T.N., HELLER, G., DUPONT, B., and O'REILLY, R.J. (1996). The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 87, 2594-2603.
22. MOVASSAGH, M., BOYER, O., BURLAND, M.C., LECLERCQ, V., KLATZMANN, D., and LEMOINE, F.M. (2000). Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum. Gene Ther. 8, 1189-1200.
23. RIDDELL, S.R., and GREENBERG, P.D. (2000). T-cell therapy of cytomegalovirus and human immunodeficiency virus infection. J. Antimicrob. Chemother. 45, 35-43.
24. SPRINGETT, G.M., MOEN, R.C., ANDERSON, s., BLAESE, R.M., and ANDERSON, W.F. (1989). Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol. 63, 3865-3869.
25. TIBERGHIEN, P., FERRAND, C., LIOURE, B., MILPIED, N., ANGONIN, R., DECONINCK, E., CERTOUX, J.M., ROBINET, E., SAAS, P., PETRACCA, B., JUTTNER, C., REYNOLDS, C.W., LONGO, D.L., HERVE, P., and CAHN, J.Y. (2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97, 63-72.